Skip to main content

Day: May 31, 2023

Gentex Announces Second Quarter 2023 Cash Dividend

ZEELAND, Mich., May 31, 2023 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX), the Zeeland, Michigan-based supplier of digital vision, connected car, dimmable glass, and fire protection technologies, today announced that its Board of Directors recently declared a quarterly cash dividend of $0.12 (12 cents) per share that will be payable July 19, 2023, to shareholders of record of the common stock at the close of business on July 7, 2023. “Overall, our capital allocation strategy is focused on enabling the company’s growth by efficiently utilizing the free cash flow we generate,” said Kevin Nash, Gentex Corporation’s Chief Financial Officer. “Typically this means we start with funding capital expenditures and R&D, and then we utilize the balance for funding our M&A strategy, our share repurchase plan, and our dividend....

Continue reading

GBT’s Database Management System, Continuation Patent Expected to be granted

The continuation patent enhances the IP protection of secured, shared mobile database management system SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH ) (“GBT” or the “Company”), today announced that its continuation applications (U.S. Patent No. 11,663,167) for mobile database sharing will be granted. The database management patent protects a highly secured communication protocol and a method to produce increased processing of database objects through its networks. The continuation application enhances the scope and broadens the strength of the original patent. The technology seeks to improve to a great extent the weaknesses of known systems and methods of database management and sharing by providing an innovative method for database management and sharing over mobile devices, using a private,...

Continue reading

Trust Stamp Announces Notice of Allowance for New U.S. Patent Related to Identity Authentication Via the Control of Third-Party Accounts

Atlanta, May 31, 2023 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity Company™ providing AI-powered trust and identity services used globally across multiple sectors, announced that it has received a Notice of Allowance for an additional patent by the United States Patent and Trademark Office.  This Notice of Allowance follows an previous patent allowance announced earlier this month. The patent titled, “Systems and Methods for Identity Verification via Third-Party Account,” uses a proprietary process to establish control of one or more third-party accounts as a primary or secondary identity authentication factor and is intended to complement Trust Stamp’s AI-generated Irreversibly Transformed Identity Token (IT2) technology. Andrew Gowasack, Trust Stamp’s President, commented, “With fraudulent...

Continue reading

Adamas One Acquires Minority Equity Stake in Artificial Intelligence Solutions Provider NexGenAI Solutions Group, Inc.

Adamas to incorporate AI-driven solutions to optimize manufacturing, marketing, branding and communications related to its development of Lab-Grown Diamonds SCOTTSDALE, Ariz., May 31, 2023 (GLOBE NEWSWIRE) — Adamas One Corp. (Nasdaq: JEWL) (“Adamas One,” “Adamas” or the “Company”), The Original Lab-Grown Diamond Company™, a high-tech company that leverages proprietary technology to produce high-quality, single-crystal, Lab-Grown Diamonds for jewelry and diamond materials for industrial uses, today announces the acquisition of a 9.99 equity stake in NexGenAI Solutions Group, Inc. (“NexGenAI”), which, through its subsidiaries and affiliate entities, offers AI-driven solutions aimed at revolutionizing business operations across various sectors. As part of the all-stock transaction, Adamas will receive access to NexGenAI’s AI-driven...

Continue reading

Evaxion Announces Business Update and First Quarter 2023 Financial Results

Full read-out of the Phase 1/2a trial of EVX-02 in 10 patients with completely resected melanoma was presented at AACR in April 2023, meeting primary endpoints and demonstrating relapse-free survival in all EVX-02 completers Recent R&D Day highlighted Evaxion´s proprietary genetic adjuvant technology enhancing efficacy of DNA and mRNA vaccines Announcement of novel AI-platform for identification of a new source of therapeutic targets, ERVs (endogenous retroviruses), potentially enabling treatment of patients that are currently considered unresponsive to cancer immunotherapy Full read-out of the Phase 1/2a trial of EVX-01 in 12 patients with metastatic melanoma will be presented at the American Society for Clinical Oncology (ASCO) Meeting in June 2023 Cash and cash equivalents of $10.2 million at March 2023 sufficient to fund operations...

Continue reading

Unaudited financial report for the first quarter of 2023

The main business activity of Trigon Property Development AS is real estate development. As at 31.03.2023, AS Trigon Property Development owned one development project with an area of 12.8 hectares in the City of Pärnu, Estonia. A commercial, industrial and logistics park is planned on this area. The Company’s objective is to find companies willing to bring their business activities (industry, logistics) to the development project area of AS Trigon Property Development in Pärnu, which would add value to the land plots owned by the Company. As the main purpose of the company is to sell existing land plots, investment property was recognized as inventories. In the first quarter of 2022, a 0.53-hectare property was sold for 213,200 euros (excluding VAT). In the second quarter of 2022, a 1.0-hectare property was sold for 401,280 euros (excluding...

Continue reading

Bicycle Market Size Projected to Hit USD 228.90 Billion by 2030 | Exhibit a CAGR of 11.0%

Increasing Government Emphasis on Cycling Infrastructure to Drive Bicycle Market Growth. Rising Popularity of Adventure Sports to Boost Cycle Sales During Forecast Period. Pune, May 31, 2023 (GLOBE NEWSWIRE) — The global bicycle market size was valued at USD 101.92 billion in 2022 and is projected to grow from USD 110.38 billion in 2023 to USD 228.90 billion by 2030, exhibiting a CAGR of 11.0% during the forecast period. Due to growing awareness of the world’s health-conscious population over the past few years, the market has seen significant development. The general public uses bikes extensively for activities like commuting, fitness, sport, hiking, and other things. To cater to a wider consumer base, manufacturers therefore, offer a variety of sorts or categories specifically created for different purposes. The global...

Continue reading

scPharmaceuticals to Present at the Jefferies Healthcare Conference

BURLINGTON, Mass., May 31, 2023 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President & Chief Executive Officer, is scheduled to present at the Jefferies Healthcare Conference, which is being held June 7-9 in New York. Mr. Tucker’s presentation is scheduled for Wednesday, June 7, at 1:00 pm ET. Mr. Tucker will also be available to meet with investors on that day. A live webcast of the presentation can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scPharmaceuticals.com. About scPharmaceuticals scPharmaceuticals is a pharmaceutical...

Continue reading

BioAtla to Participate in the Jefferies Healthcare Conference

SAN DIEGO, May 31, 2023 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that the Company’s management will participate in a fireside chat and scheduled one-on-one investor meetings at the Jefferies Healthcare Conference, to be held in New York, NY June 7-9, 2023. Format: Fireside chat and scheduled one-on-one investor meetingsDate: Wednesday, June 7, 2023Time: 11:30 a.m. ETLocation: New York, NYWebcast Link: Click Here About BioAtla, Inc.BioAtla is a global clinical-stage biotechnology company with operations in San Diego, California, and in Beijing, China through our contractual relationship with BioDuro-Sundia, a provider of preclinical development...

Continue reading

Nokia selected by MetaLINK to expand fixed wireless broadband access across rural America

Press Release Nokia selected by MetaLINK to expand fixed wireless broadband access across rural AmericaDeal will see MetaLINK provide superior fixed wireless access coverage boosting network capacity to address growing customer demand in Ohio Nokia’s first win with MetaLINK in partnership with Winncom Technologies Nokia AirScale radio and baseband portfolio supports US Internet Service Providers (ISPs) through its flexible and efficient scaling capacity31 May 2023DALLAS – Nokia today announced that it has been selected by MetaLINK to provide fixed wireless access coverage and boost broadband network capacity in Northwest Ohio, Northeast Indiana, and parts of Southern Michigan. Using Nokia’s Citizens Broadband Radio Service (CBRS) RAN portfolio, MetaLINK will address the growing demand for broadband coverage by connecting more...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.